While critical for transducing signals emanating from oncogenes such as KRAS [13] and other receptor tyrosine kinases including ErbB-family receptors [14], the pathway is not known to play a critical role in HER2-amplified cancers. The gene discussed is ERBB2; the disease is cancer.